1. Home
  2. VIVK vs LEXX Comparison

VIVK vs LEXX Comparison

Compare VIVK & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIVK
  • LEXX
  • Stock Information
  • Founded
  • VIVK 2006
  • LEXX 2004
  • Country
  • VIVK United States
  • LEXX Canada
  • Employees
  • VIVK N/A
  • LEXX N/A
  • Industry
  • VIVK Oilfield Services/Equipment
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VIVK Energy
  • LEXX Health Care
  • Exchange
  • VIVK Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • VIVK 20.9M
  • LEXX 23.9M
  • IPO Year
  • VIVK N/A
  • LEXX N/A
  • Fundamental
  • Price
  • VIVK $0.26
  • LEXX $0.82
  • Analyst Decision
  • VIVK
  • LEXX Strong Buy
  • Analyst Count
  • VIVK 0
  • LEXX 1
  • Target Price
  • VIVK N/A
  • LEXX $4.00
  • AVG Volume (30 Days)
  • VIVK 8.0M
  • LEXX 1.3M
  • Earning Date
  • VIVK 11-18-2025
  • LEXX 11-25-2025
  • Dividend Yield
  • VIVK N/A
  • LEXX N/A
  • EPS Growth
  • VIVK N/A
  • LEXX N/A
  • EPS
  • VIVK N/A
  • LEXX N/A
  • Revenue
  • VIVK $124,048,464.00
  • LEXX $615,923.00
  • Revenue This Year
  • VIVK N/A
  • LEXX $46.98
  • Revenue Next Year
  • VIVK N/A
  • LEXX $17.26
  • P/E Ratio
  • VIVK N/A
  • LEXX N/A
  • Revenue Growth
  • VIVK 98.83
  • LEXX 49.85
  • 52 Week Low
  • VIVK $0.24
  • LEXX $0.77
  • 52 Week High
  • VIVK $1.68
  • LEXX $3.28
  • Technical
  • Relative Strength Index (RSI)
  • VIVK 28.70
  • LEXX 40.14
  • Support Level
  • VIVK $0.26
  • LEXX $0.88
  • Resistance Level
  • VIVK $0.49
  • LEXX $1.01
  • Average True Range (ATR)
  • VIVK 0.08
  • LEXX 0.12
  • MACD
  • VIVK -0.01
  • LEXX -0.06
  • Stochastic Oscillator
  • VIVK 2.61
  • LEXX 3.11

About VIVK Vivakor Inc.

Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: